AQILION

AQILION is a Helsingborg-based biotech investment and development company that identifies, finances, and develops promising pharmaceutical projects from early research to clinical proof of concept. The company operates as a portfolio model, building a diversified pipeline of drug candidates across inflammation, oncology, and metabolic diseases, and partners with academic groups and pharma companies to advance projects. AQILION is listed on Nasdaq First North.